Listing 1 - 10 of 204 | << page >> |
Sort by
|
Choose an application
Choose an application
Choose an application
W 74 Medical economics. Health care costs (General) --- W 74 Medical economics. Health care costs (General) --- W 74 Medical economics. Health care costs (General) --- Health Care Costs --- Health Care Costs --- Health Care Costs --- Longevity --- Longevity --- Longevity --- Aged --- Aged --- Aged
Choose an application
Choose an application
Choose an application
Etre malade... est aussi parfois un danger pour la santé financière du patient.Les soins de santé sont bien développés en Belgique et sont en principe accessibles à tout le monde. Mais dans certains cas, cette accessibilité peut être problématique. Les frais médicaux peuvent quelquefois être très élevés. Une situation d'autant plus poignante pour quiconque doit vivre avec un faible revenu ou avec une indemnité d'incapacité de travail ou d'invalidité. Dans un premier chapitre, quatre exemples illustrent la façon dont certaines dépenses de santé peuvent grimper, et comment elles peuvent briser l'équilibre financier d'un ménage.La suite de ce dossier est consacrée à un examen des principales mesures qui ont exercé un impact sur les frais à charge du patient au cours des quinze dernières années et à l'analyse des parts publique et privée dans les dépenses et le financement des soins.
Choose an application
The aim of The Elgar Companion to Health Economics is to take an audience of advanced undergraduates, postgraduates and researchers to the frontier of research in health economics, by providing them with short and easily readable introductions to key topics. The volume brings together 50 chapters written by more than 90 leading international contributors. The contributions to the Companion are concise and focus on specific concepts, methods and key evidence.The Companion is a comprehensive and authoritative original reference volume covering theoretical and empirical issues in health economics with a balanced range of material on equity and efficiency in health care systems, health technology assessment and issues of concern for low and middle income countries. It is organised into two broad sections. The first deals with the economics of population health and of health care systems, analysed with both equity and efficiency goals in mind. The second covers the conceptual and practical issues that arise in the evaluation of health care technologies: most often applied to pharmaceuticals but also relevant for other interventions.Many of the contributions address topical and policy-relevant issues including: the economic causes of the growth of obesity in the West, the link between illicit drug use and crime, the consequences of leaving people uninsured against the costs of health care, the impact of globalisation on the international trade in health care services, the role of informal payments in many health care systems, what equal treatment for equal needs means in practice, whether direct-to-consumer advertising of pharmaceuticals is desirable, and how economic evidence is influencing the way that new technologies are made available to patients. Other chapters stress the research done by health economists to develop theoretical models and empirical methods that illuminate the workings of health care systems.
Choose an application
Choose an application
Choose an application
Listing 1 - 10 of 204 | << page >> |
Sort by
|